Herbas VPB

Print
EN | LT
LT - Tricikliai junginiai, pasižymintys specifiniu aktyvumu integrinams, būtent alfa-gama-beta-3 integrinui, jų gavimo būdas, tarpiniai junginiai šiems junginiams gauti, jų panaudojimas vaistams ir farmacinės kompozicijos, į kurias įeina šie junginiai
EN - TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARY ALPHA-GAMA-BETA-3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL.: (2006.01) A61K 31/00
A61K 31/185
A61K 31/357
A61K 31/415
A61K 31/4164
A61K 31/505
A61P 19/00
C07C 45/00
C07C 49/00
C07C 281/00
C07C 337/00
C07D 233/00
C07D 239/00
C07D 317/00
Patent
(11) Number of the document 4535
(13) Kind of document B
(21) Application number 98-145
(22) Date of filing the application 1998-10-15
(41) Date of publication of the application 1999-03-25
(45) Date of publication of patent 1999-08-25
PCT application
(86) Number PCT/FR97/00487
Date 1997-03-20
PCT application publication
(87) Number WO 97/34865
Date 1997-09-25
Priority applications
(30) Number Date Country code
96/03437 1996-03-20 FR
Applicant
(71) HOECHST MARION ROUSSEL, 1 Terrasse Bellini, F-92800 Puteaux, FR
GENENTECH, INC., 460 Point San Bruno Boulevard, South San Francisco, CA 94080-4990, US
Inventors
(72) Serge BERNARD, FR
Denis CARNIATO, FR
Jean Francois GOURVEST, FR
Jean Georges TEUTSCH, FR
Jochen KNOLLE, DE
Hans Ulrich STILZ, DE
Volkmar WEHNER, DE
Sarah C. BODARY, US
Thomas R. GADEK, US
Robert S. MCDOWELL, US
Robert M. PITTI, US
Grantee
(73) GENENTECH, INC., 460 Point San Bruno Boulevard, South San Francisco, CA 94080-4990, US
AVENTIS PHARMA S.A., 20, Avenue Raymond Aron, 92160 Antony, FR
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARY ALPHA-GAMA-BETA-3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
Last renewal fee
Payment date Validity (years) Amount
2003-03-13 7 560.00 LTL
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2004-03-20